Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF
Open Access
- 1 April 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (4) , 471-477
- https://doi.org/10.1023/a:1011108722666
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukinsImmunologic Research, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- The Human Hematopoietic Colony-Stimulating FactorsScience, 1987
- Dose-response is alive and well.Journal of Clinical Oncology, 1986
- Biologic properties in vitro of a recombinant human granulocyte- macrophage colony-stimulating factorBlood, 1986
- The Granulocyte-Macrophage Colony-Stimulating FactorsScience, 1985
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980